Ying-Hong Feng

Title: Innovations of Ying-Hong Feng in Cancer Research

Introduction

Ying-Hong Feng is a notable inventor based in Germantown, MD, who has made significant contributions to the field of cancer research. He holds two patents that focus on innovative methods for detecting and treating cancers. His work is pivotal in advancing the understanding of cancer markers and therapeutic approaches.

Latest Patents

Ying-Hong Feng's latest patents revolve around the use of truncated proteins as cancer markers. These patents disclose methods and reagents for detecting and treating cancers or potential cancers. In one embodiment, methods and reagents for detecting truncated forms of the P2X protein in cells are described. Additionally, he outlines methods and reagents for increasing the amount and/or activity of full-length P2X in cells. Furthermore, he provides methods and reagents for decreasing the amount and/or activity of truncated P2X in cells.

Career Highlights

Throughout his career, Ying-Hong Feng has worked with esteemed organizations such as the Henry M. Jackson Foundation for the Advancement of Military Medicine and University Hospitals of Cleveland. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ying-Hong Feng has collaborated with notable colleagues, including George Gorodeski and Xin Li. These partnerships have enhanced his research efforts and expanded the impact of his innovations in cancer detection and treatment.

Conclusion

Ying-Hong Feng's contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches to detecting and treating cancers are paving the way for future breakthroughs in the field.